Spectrum Pharmaceuticals (SPPI) Sees Downside Action
Up)
Spectrum Pharmaceuticals, Inc. (Nasdaq: SPPI) is seeing a sharp downside move, triggering the short sale rule. Shares now sit down 8%. We have not seen any news to explain the downside action.
Get immediate access to market moving news and alerts with StreetInsider.com Premium - FREE TRIAL!
Get immediate access to market moving news and alerts with StreetInsider.com Premium - FREE TRIAL!
You May Also Be Interested In
- Spectrum Pharmaceuticals and Allos Therapeutics Announce Additional Extension of Tender Offer Period for Shares of Allos Therapeutics
- Vodafone (VOD) Volatility Pops Early, Shares Inch Higher
- Facebook (FB) Short Interest Nears Double-Digit Levels
Create E-mail Alert Related Categories
Trader TalkSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
